Relapses after treatment with rituximab in a patient with multiple sclerosis and anti-myelin-associated glycoprotein polyneuropathy

Archives of Neurology

Volumn 64, Issue 10, 2007, Pages 1531-1533

  Benedetti, Luana ^a   Franciotta, Diego ^b   Vigo, Tiziana ^a   Grandis, Marina ^a   Fiorina, Elisabetta ^a   Ghiglione, Elisabetta ^a   Roccatagliata, Luca ^a   Mancardi, Giovanni Luigi ^a   Uccelli, Antonio ^a   Schenone, Angelo ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; RITUXIMAB;

ADULT; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID; CLINICAL FEATURE; HUMAN; MALE; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGY; POLYNEUROPATHY; PRIORITY JOURNAL; RECURRENT DISEASE; SEROLOGY;

ANTIBODIES, MONOCLONAL; AUTOANTIBODIES; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; ELECTROPHYSIOLOGY; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; ISOELECTRIC FOCUSING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELIN-ASSOCIATED GLYCOPROTEIN; NEUROLOGIC EXAMINATION; POLYNEUROPATHIES; RECURRENCE;

EID: 35348819430     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.64.10.1531     Document Type: Article

References (17)

1. Benedetti L, Briani C, Grandis M, et al. Predictors of response to rituximab in patients with neuropathy and anti-myelin associated glycoprotein immunoglobulin M. J Peripher Nerv Syst. 2007;12(2):102-107.
2. Dalakas MC, Rakocevic G, Salajegheh K, Dambrosia J, Raghavan R, McElroy B. A double-blind, placebo-controlled study of rituximab in patients with anti-MAG antibody-demyelinating polyneuropathy. Ann Neurol. 2006;60(suppl 3):S91-S95.
3. Monson NL, Cravens PD, Frohman EM, Hawker K, Racke MK. Effect of rituximab on the peripheral blood and cerebrospinal fluid B cells in patients with primary progressive multiple sclerosis. Arch Neurol. 2005;62(2):258-264.
4. Stuve O, Cepok S, Elias B, et al. Clinical stabilization and effective B-lymphocyte depletion in the cerebrospinal fluid and peripheral blood of a patient with fulminant relapsing-remitting multiple sclerosis. Arch Neurol. 2005;62(10):1620-1623.
5. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology. 1983;33(11):1444- 1452.
6. Kelly JJ Jr. The electrodiagnostic findings in polyneuropathies associated with IgM monoclonal gammopathies. Muscle Nerve. 1990;13(12):1113-1117.
7. Kleyweg RP, van der Mechè FGA, Schmitz PIM. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barrè syndrome. Muscle Nerve. 1991;14(11):1103-1109.
8. Merkies I, Schmitz P, Van Der Mechè F, Van Doorn P; Inflammatory Neuropathy Cause and Treatment (INCAT) Group. Psychometric evaluation of a new sensory scale in immune-mediated polyneuropathies. Neurology. 2000;54(4):943-949.
9. Lunn MPT, Nobile-Orazio E. Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies. Cochrane Database Syst Rev. 2006;(2):CD002827.
10. Gorson KC, Natarajan N, Ropper AH, Weinstein R. Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: a prospective pilot trial. Muscle Nerve. 2007;35(1):66-69.
11. Broglio L, Lauria G. Worsening after rituximab treatment in anti-MAG neuropathy. Muscle Nerve. 2005;32(3):378-379.
12. Trefouret S, Azulay JP, Pouget J, Boucraut J, Serratrice G. Late onset multiple sclerosis and monoclonal gammopathy: a fortuitous association? [in French] Rev Neurol (Paris). 1996;152(8-9):554-556.
13. Rentzos M, Michalopoulou M, Gotosidis K, et al. Unusual association of multiple sclerosis with monoclonal gammopathy of undetermined significance: two case reports. Funct Neurol. 2004;19(4):253-256.
14. Link H, Huang Y-M. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness. J Neuroimmunol. 2006;180(1-2):17-28.
15. Pasqualetti P, Collacciani A, Casale R. Risk of monoclonal gammopathy of undetermined significance: a case-referent study. Am J Hematol. 1996;52(3):217-220.
16. Saiz A, Carreras E, Berenguer J, et al. MRI and CSF oligoclonal bands after autologous hematopoietic stem cell transplantation in MS. Neurology. 2001;56(8):1084-1089.
17. Pilarski LM, Ruether BA, Mant MJ. Abnormal function of B lymphocytes from peripheral blood of multiple myeloma patients: lack of correlation between the number of cells potentially able to secrete immunoglobulin M and serum immunoglobulin M levels. J Clin Invest. 1985;75(6):2024-2029.